Clinical Trials Browser

Interventional × Hepatecellular Carcinoma × Bevacizumab × Clear all

NCT07327788 2026-01-13

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

Phase 2 Recruiting

Hepatecellular Carcinoma